153 related articles for article (PubMed ID: 36474172)
41. Leading determinants of incident dementia among individuals with and without the apolipoprotein E ε4 genotype: a retrospective cohort study.
Ye S; Roccati E; Wang W; Zhu Z; Kiburg K; Huang Y; Zhang X; Zhang X; Liu J; Tang S; Hu Y; Ge Z; Yu H; He M; Shang X
BMC Neurol; 2024 Feb; 24(1):71. PubMed ID: 38378514
[TBL] [Abstract][Full Text] [Related]
42. Education and Cardiovascular Health as Effect Modifiers of APOE ε4 on Dementia: The Atherosclerosis Risk in Communities Study.
Lee M; Hughes TM; George KM; Griswold ME; Sedaghat S; Simino J; Lutsey PL
J Gerontol A Biol Sci Med Sci; 2022 Jun; 77(6):1199-1207. PubMed ID: 34614170
[TBL] [Abstract][Full Text] [Related]
43. Apolipoprotein E ε4 Modifies the Effect of Possible Anticholinergic Drugs on Incident Dementia: The Shanghai Aging Study.
Chi D; Wu W; Zhao Q; Xiao Z; Luo J; Wang B; Ding D
J Am Med Dir Assoc; 2023 Apr; 24(4):526-532. PubMed ID: 36842452
[TBL] [Abstract][Full Text] [Related]
44. Associations between depression, sleep disturbance, and apolipoprotein E in the development of Alzheimer's disease: dementia.
Burke SL; Maramaldi P; Cadet T; Kukull W
Int Psychogeriatr; 2016 Sep; 28(9):1409-24. PubMed ID: 27020605
[TBL] [Abstract][Full Text] [Related]
45. Determinants, MRI correlates, and prognosis of mild cognitive impairment: the Rotterdam Study.
de Bruijn RF; Akoudad S; Cremers LG; Hofman A; Niessen WJ; van der Lugt A; Koudstaal PJ; Vernooij MW; Ikram MA
J Alzheimers Dis; 2014; 42 Suppl 3():S239-49. PubMed ID: 24825566
[TBL] [Abstract][Full Text] [Related]
46. Hearing Loss and Risk of Mild Cognitive Impairment and Dementia: Findings from the Singapore Longitudinal Ageing Study.
Heywood R; Gao Q; Nyunt MSZ; Feng L; Chong MS; Lim WS; Yap P; Lee TS; Yap KB; Wee SL; Ng TP
Dement Geriatr Cogn Disord; 2017; 43(5-6):259-268. PubMed ID: 28420004
[TBL] [Abstract][Full Text] [Related]
47. Associations Between Midlife Vascular Risk Factors and 25-Year Incident Dementia in the Atherosclerosis Risk in Communities (ARIC) Cohort.
Gottesman RF; Albert MS; Alonso A; Coker LH; Coresh J; Davis SM; Deal JA; McKhann GM; Mosley TH; Sharrett AR; Schneider ALC; Windham BG; Wruck LM; Knopman DS
JAMA Neurol; 2017 Oct; 74(10):1246-1254. PubMed ID: 28783817
[TBL] [Abstract][Full Text] [Related]
48. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
49. Sex Difference in the Association of APOE4 with Memory Decline in Mild Cognitive Impairment.
Wang X; Zhou W; Ye T; Lin X; Zhang J;
J Alzheimers Dis; 2019; 69(4):1161-1169. PubMed ID: 31127771
[TBL] [Abstract][Full Text] [Related]
50. Lack of reliable evidence for a distinctive ε4-related cognitive phenotype that is independent from clinical diagnostic status: findings from the Australian Imaging, Biomarkers and Lifestyle Study.
Foster JK; Albrecht MA; Savage G; Lautenschlager NT; Ellis KA; Maruff P; Szoeke C; Taddei K; Martins R; Masters CL; Ames D;
Brain; 2013 Jul; 136(Pt 7):2201-16. PubMed ID: 23737466
[TBL] [Abstract][Full Text] [Related]
51. Apolipoprotein E4 genotype does not increase risk of HIV-associated neurocognitive disorders.
Morgan EE; Woods SP; Letendre SL; Franklin DR; Bloss C; Goate A; Heaton RK; Collier AC; Marra CM; Gelman BB; McArthur JC; Morgello S; Simpson DM; McCutchan JA; Ellis RJ; Abramson I; Gamst A; Fennema-Notestine C; Smith DM; Grant I; Vaida F; Clifford DB;
J Neurovirol; 2013 Apr; 19(2):150-6. PubMed ID: 23408335
[TBL] [Abstract][Full Text] [Related]
52. APOE4 leads to blood-brain barrier dysfunction predicting cognitive decline.
Montagne A; Nation DA; Sagare AP; Barisano G; Sweeney MD; Chakhoyan A; Pachicano M; Joe E; Nelson AR; D'Orazio LM; Buennagel DP; Harrington MG; Benzinger TLS; Fagan AM; Ringman JM; Schneider LS; Morris JC; Reiman EM; Caselli RJ; Chui HC; Tcw J; Chen Y; Pa J; Conti PS; Law M; Toga AW; Zlokovic BV
Nature; 2020 May; 581(7806):71-76. PubMed ID: 32376954
[TBL] [Abstract][Full Text] [Related]
53. Metabolic Syndrome and Cognitive Impairment among High Socioeconomic, Nondemented Older US Adults.
Martinez-Miller EE; Kohl HW; Barlow CE; Willis BL; DeFina LF
J Am Geriatr Soc; 2019 Jul; 67(7):1437-1443. PubMed ID: 30854644
[TBL] [Abstract][Full Text] [Related]
54. Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
Fleisher AS; Chen K; Liu X; Ayutyanont N; Roontiva A; Thiyyagura P; Protas H; Joshi AD; Sabbagh M; Sadowsky CH; Sperling RA; Clark CM; Mintun MA; Pontecorvo MJ; Coleman RE; Doraiswamy PM; Johnson KA; Carpenter AP; Skovronsky DM; Reiman EM
Neurobiol Aging; 2013 Jan; 34(1):1-12. PubMed ID: 22633529
[TBL] [Abstract][Full Text] [Related]
55. Brain Oxygen Extraction by Using MRI in Older Individuals: Relationship to Apolipoprotein E Genotype and Amyloid Burden.
Lin Z; Sur S; Soldan A; Pettigrew C; Miller M; Oishi K; Bilgel M; Moghekar A; Pillai JJ; Albert M; Lu H
Radiology; 2019 Jul; 292(1):140-148. PubMed ID: 31012816
[TBL] [Abstract][Full Text] [Related]
56. Risk and protective factors for cognitive impairment in persons aged 85 years and older.
Roberts RO; Cha RH; Mielke MM; Geda YE; Boeve BF; Machulda MM; Knopman DS; Petersen RC
Neurology; 2015 May; 84(18):1854-61. PubMed ID: 25854867
[TBL] [Abstract][Full Text] [Related]
57. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study.
Irie F; Masaki KH; Petrovitch H; Abbott RD; Ross GW; Taaffe DR; Launer LJ; White LR
Arch Gen Psychiatry; 2008 Aug; 65(8):906-12. PubMed ID: 18678795
[TBL] [Abstract][Full Text] [Related]
58. Effects of race, baseline cognition, and APOE on the association of affective dysregulation with incident dementia: A longitudinal study of dementia-free older adults.
Ebrahim IM; Ghahremani M; Camicioli R; Smith EE; Ismail Z
J Affect Disord; 2023 Jul; 332():9-18. PubMed ID: 36997127
[TBL] [Abstract][Full Text] [Related]
59. High levels of serum C-reactive protein are associated with greater risk of all-cause mortality, but not dementia, in the oldest-old: results from The 90+ Study.
Kravitz BA; Corrada MM; Kawas CH
J Am Geriatr Soc; 2009 Apr; 57(4):641-6. PubMed ID: 19245412
[TBL] [Abstract][Full Text] [Related]
60. Neuropsychiatric symptoms, apolipoprotein E gene, and risk of progression to cognitive impairment, no dementia and dementia: the Aging, Demographics, and Memory Study (ADAMS).
Beaudreau SA; Kaci Fairchild J; Spira AP; Lazzeroni LC; O'Hara R
Int J Geriatr Psychiatry; 2013 Jul; 28(7):672-80. PubMed ID: 22927174
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
